142 related articles for article (PubMed ID: 19276972)
1. Collagen type I may influence the expression of E-cadherin and beta-catenin in carcinoma ex-pleomorphic adenoma.
Araújo VC; Demasi AP; Furuse C; Altemani A; Alves VA; Freitas LL; Araújo NS
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):312-8. PubMed ID: 19276972
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
3. Tenascin and fibronectin expression in carcinoma ex pleomorphic adenoma.
Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):48-53. PubMed ID: 18091320
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
5. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
[TBL] [Abstract][Full Text] [Related]
9. Maspin expression in carcinoma ex pleomorphic adenoma.
Martins MT; Altemani A; Freitas L; Araújo VC
J Clin Pathol; 2005 Dec; 58(12):1311-4. PubMed ID: 16311353
[TBL] [Abstract][Full Text] [Related]
10. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
11. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
[TBL] [Abstract][Full Text] [Related]
12. FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures.
Martinez EF; Demasi AP; Miguita L; Altemani A; Araújo NS; Araújo VC
Oncol Rep; 2010 Jul; 24(1):155-60. PubMed ID: 20514456
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Ki-67, cyclin E, and p63 in benign and malignant human pleomorphic adenoma.
Zhu X; Zhang J; Chen X; Feng X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):667-72. PubMed ID: 22668626
[TBL] [Abstract][Full Text] [Related]
14. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study.
do Prado RF; Consolaro A; Taveira LA
Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
16. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
18. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and α-SMA expression in the epithelial-mesenchymal transition of salivary glands pleomorphic adenomas.
Enescu A; Enescu AŞ; Florou C; Petrescu F
Rom J Morphol Embryol; 2014; 55(4):1383-7. PubMed ID: 25611270
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
